bio-equity

AKA 2Blockchains

[bio-equity @BioEquity]

Great news for $VKTX too https://t.co/ydMA5TZpz4

[Odi Bruckman @odibro]

$MDGL MGL-3196 Achieves Liver Biopsy Endpoints in Patients with Non-alcoholic Steatohepatitis (NASH) at 36 Weeks in Phase 2 Clinical Trial https://t.co/wp3Z72wrZ4

[Brad Loncar @bradloncar]

My #ASCO18 preview. https://t.co/VO0epmQ8uj

[David Crow @bydavidcrow]

Mylan turns screws on Pfizer over EpiPen shortage; sends crack team to troubled St Louis factory to try to fix manufacturing issues. $Myl $pfe https://t.co/4PHKqk9BrX

[Sports_Bios @Sports_bios]

$ALXN why????? 855 MM deal to buy a big pot of pricing concerns target on its back..

[Odi Bruckman @odibro]

$ALKS Alkermes Receives Refusal to File Letter From FDA for ALKS 5461

[Sports_Bios @Sports_bios]

$BHVN stats sign.. but clin irrelevant with this kind of efficacy delta.. bye bye..

[Vala Afshar @ValaAfshar]

How to improve your listening skills:

1 talk less
2 do not interrupt
3 maintain direct eye contact
4 put your phone down
5 listen with your eyes; look for the unsaid
6 be interested
7 if you are waiting for a pause, so that you can speak, then you're not actively listening

[Jonathan Wai @JonathanLWai]

Scientists are real heroes. 5 billion lives saved by some 100 or so incredible minds. From Steven Pinker's Enlightenment Now.

[Don't blame me, you invested in garbage! @subach]

$OMER simple math to work out that Omidria can be priced cheaply enough to take most of the market & still bring in ~100M in annual revenue in US. & with pricing worked out, they can finally expand into EU and Asia.

[Stoneman Douglas Football @MSDEagles]

@ESPN please nominate Coach Aaron Feis, our fallen hometown HERO during the MSD school shooting for 2018 @ESPYS Arthur Ashe Courage Award

[bio-equity @BioEquity]

@adamfeuerstein Yes lets run a placebo arm with a condition that has a higher mortality rate than pancreatic cancer. Brilliant analysis, Adam

[Odi Bruckman @odibro]

$VBLT Receives undisclosed Milestone Payment From NanoCarrier Under Licensing Agreement for VB-111 in Japan https://t.co/EgTspwVFm1

[Brad Loncar @bradloncar]

Here's Bristol's press release. This news on the TMB biomarker is potentially a very important finding for immunotherapy, if true. This will have been an important study result for that reason alone. https://t.co/mVNxfJlSat

[bio-equity @BioEquity]

@adamfeuerstein Not new or news at all. In fact its the same old pump from you where we have known about them targeting a larger percentage for some time. I assume the $VRTX checks keep coming, eh Adam? Hard to turn down on your salary I suppose

[CNBC @CNBC]

BREAKING: Berkshire Hathaway, Amazon, and JPMorgan Chase partner on health care for their US employees through creation of “an independent company that is free from profit-making incentives and constraints” https://t.co/Klhlon51T5

[Matthew Herper @matthewherper]

This is really cool: $MRK spinout grabs some assets and launches a quest for the Holy Grail in antibiotics R&D - https://t.co/HVfRLqYGl5 by @JohnCEndpts

[bio-equity @BioEquity]

Dirty https://t.co/glFAZMxDwr

[Jssr @juliaskripkaser]

$ARDM One of the ugliest CRLs ever seen. FDA wants another 2-year Ph3 with "meaningful clinical endpoints". I kinda feel bad.

[Open Outcrier @OpenOutcrier]

Upgrades 1/26: $AGI $AROC $AUY $CEQP $COMM $EGN $EGO $EXPO $FE $GILD $GSS $INTC $JACK $KBH $MAC $MRTN $NGG $SITE $SLG $STM $TRV $WHR $ZG

[Open Outcrier @OpenOutcrier]

Downgrades 1/26: $AG $AZPN $BANC $BBBY $CNS $FHB $FSB $FTNT $GDS $GE $MBFI $NWL $QD $RCI $SBUX $SCMP $TAHO $THO $UNP $WGO $WHR

[bio-equity @BioEquity]

The float already scares me on $SGYP. I am staying away https://t.co/t98kIzvlbl